UK homebuilder stocks screen attractively despite their strong share price performance in late 2023. While share prices no longer factor in the exceedingly downbeat outlook that...
The NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against Respiratory Syncytial Virus (RSV), the winter infection known as...
Nvidia cedes title of most valuable US listed company back to Microsoft as Apple regains No. 2 spot amidst continued AI frenzy Nvidia has ceded the...